Virological outcome and frequency of low-level viremia in patients receiving generic dolutegravir-containing regimen at a large tertiary care clinic in Western India

BACKGROUND: Dolutegravir (DTG) is widely used for the management of naïve and treatment-experienced HIV-infected patients. Low-level viremia (LLV) is common in patients receiving nonnucleoside reverse transcriptase inhibitor- and protease inhibitor-containing regimens. However, the incidence of LLV...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Atul K., Patel, Ketan K., Pujari, Sanjay, Patel, Jagdish K., Kumar, Ambuj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579596/
https://www.ncbi.nlm.nih.gov/pubmed/34765935
http://dx.doi.org/10.4103/ijstd.IJSTD_34_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579596/
https://www.ncbi.nlm.nih.gov/pubmed/34765935
http://dx.doi.org/10.4103/ijstd.IJSTD_34_20

Ejemplares similares